top of page

TMS: Struggling with Depression?

Why TMS?
  • Non-invasive
  • No severe symptoms
  • Proven efficacy 
  • 20-minute sessions
  • No recovery time
  • Non-habit forming
  • Covered by insurance
What is TMS? Trans-cranial Magnetic Stimulation therapy is a game changer for patients struggling with depression and anxiety. Using a non-invasive, FDA-approved technique, we are able to deliver magnetic stimulation to the parts of the brain that affect mood. Our expert staff uses the latest technology to achieve the best results possible, with an 82% success rate in reducing symptoms and even complete remission in some patients.
WaveDXS proudly uses Brainsway deep TMS machines exclusively. Contact us today to learn more about this revolutionary therapy! Click the Brainsway logo below for clinical research articles published.
Wave TMS Q&A:

Q: What does the Wave TMS treatment entail?
A: Wave TMS is a comprehensive depression treatment program that combines cutting-edge technology, telemedicine consultations, and personalized care. We provide patients with a neurodiagnostic workup to rule out any contraindications and an initial treatment and brain mapping appointment. 6 weeks of treatment appointments are also followed in the program.

Q: What is the scheduling process for Wave TMS?
A: The scheduling process for Wave TMS is simple and straightforward. Once you contact us, we'll schedule a telemedicine consultation to assess your needs. Following that, we'll provide you with a neurodiagnostic workup to rule out any contraindications and schedule your initial treatment and brain mapping appointment. From there, we'll schedule daily treatment appointments to help meet your goals.

Q: How do telemedicine consultations work with Wave TMS?
A: Telemedicine consultations with Wave TMS allow you to receive the care you need from the comfort of your home. Our providers will conduct a thorough assessment to understand your specific needs and create a personalized treatment plan for you.
Affordable Cash Pay Plans:

Healthcare plans only cover TMS for patients with a diagnosis of severe depression, but deep TMS can be extremely beneficial for other applications. Such as traumatic brain injury, concussion, anxiety, and degenerative diseases to improve cognitive function. For this we have created affordable cash pay options.

40 Treatments: $100/treatment

30 Treatments: $110/treatment

20 Treatments: $115/treatment

10 Treatments: $120/treatment

Single Treatments: $150/treatment

Payment plans available. Call today for an appointment!


Clinical Studies of TMS Benefits in Other Applications

Background: Post-concussive symptoms (PCSs) are common, disabling, and challenging to manage. Evolving models of concussion pathophysiology suggest evidence of brain network dysfunction that may be amenable to neuromodulation. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential novel treatment option for PCSs.

Objectives: To systematically review rTMS trials for the treatment of symptoms following concussion/mild traumatic brain injury (mTBI).

Materials and methods: We conducted a systematic review of Pubmed/Medline, Embase, and PsychINFO databases were searched up to May 19, 2020. Studies were included if they were prospective rTMS treatment studies of patients with mTBI/concussion. Variables including patient demographics, study design, rTMS protocol parameters, primary outcome measures, and efficacy data were extracted and qualitatively synthesized. rTMS methodology and study quality were also evaluated.

Results: Of the 342 studies identified, 11 met eligibility criteria and were included for synthesis. Forty-one percent of patients were female and age ranged from 18 to 65 (average age = 38.5 years). Post-concussive depression (seven studies) and headache (four studies) were the most commonly investigated symptoms. The majority of trials were sham-controlled with randomized control trial (RCT) designs, but all were small pilot samples (n < 30). Methodological heterogeneity and a low number of identified trials precluded quantitative meta-analysis. Regarding rTMS for post-concussive depression, positive results were found in two out of four studies with depression as a primary outcome, and all three studies that assessed depression as a secondary outcome. All four rTMS studies for post-concussive headache reported positive results.

Conclusions: rTMS for the treatment of concussion/mTBI shows promising preliminary results for post-concussive depression and headache, symptoms that otherwise have limited effective treatment options. More studies with larger sample sizes are needed to further establish potential efficacy.

© 2020 International Neuromodulation Society.

TMS and Alzheimers disease


Patients diagnosed with Alzheimer disease (AD) show severe cognitive deficits. Decline in memory, language, and executive function have repeatedly been reported. Although AD affects 60% to 80% of demented elderly patients, there is currently no cure and limited treatment alternatives.


The aim of the study was to evaluate the feasibility of stimulating prefrontal cortex (PFC) with deep transcranial magnetic stimulation (Deep TMS™) to ameliorate cognitive deficits in patients suffering from AD.


Eleven patients (6 males; mean [SD] age, 76 [7] years) in moderate to severe stages of AD received Deep TMS over the PFC for 20 sessions. Computerized battery (Mindstreams [MS]) and neuropsychological testing (Addenbrooke Cognitive Examination [ACE]) were used to assess cognitive performance before and after treatment.


Compared with baseline, 60% of patients performed better on the MS battery and 77% of patients performed better on the ACE testing at the end of Deep TMS treatment. None of the patients performed worse on both tests at the end of treatment. The Deep TMS effects on the group mean in ACE and MS approached significance (p=0.065 and p=0.086, respectively). A Deep TMS-induced improvement in the ACE was significant (p=0.001) on patients in more progressed stage (n = 6). Change in ACE negatively correlated with score at baseline.


In sum, the current report of this novel technique indicates that deep stimulation might lead to preservation and even improvement of cognitive functions, at least during the time of treatment. Further examinations should report of long-term effects of this technique.

bottom of page